medigraphic.com
ISSN 1028-4818 (Electronic)

2014, Number 4

<< Back Next >>

Mul Med 2014; 18 (4)

Viral hepatitis. Biblographic updating

Quesada FAJ, Maillo FAE, Arévalos SM, Espinosa GAI

Language: Spanish
References: 11
Page: 1-13
PDF size: 192.08 Kb.


ABSTRACT

The hepatic illnesses sometimes occur without presenting symptoms, which is the reason why they are also called the silent diseases. It was performed this bibliographic updating with the aim to know the epidemiological aspects, current processes related with the risk factors of viral Hepatitis, the clinical signs, its prevention, complications and treatment. This investigation refers to a bibliographic updating on national and international experiences, comment some definitions and the clinical – epidemiological approaches to diminish the morbimortality indicators that generate the complications produced, especially by agents of the type B and C. It was made a review of the databases in PubMed, CUMED and LILACS, since 2010 until the 2014, there were consulted other resources in Internet like the web pages of institutions and associations of the Biomedical Sciences. There were included review and original articles. In several international articles it was recognized that there are social factors that influence in the risk and vulnerability to acquire these infectious diseases, the sex, the discrimination, the stigma and the social marginalization, but there are few actions to prevent hepatitis, if we evaluate that in several cases there are asymptomatic carriers, which are not detected in the focus controls, that is why the infectious source is not interrupted and the transmission continues, especially in the type B . In the revision of the national literature we state that they still exist social factors that affect the risk to suffer the illness, unlike other countries, our National Health System provides programs and actions of risk prevention towards viral Hepatitis.


REFERENCES

  1. Lesmana LA, Lesmana CR, Pakasi LS, Krissnuhoni E. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity. Acta Med Indones [Internet]. 2012 [citado 8 jul 2014]; 44(1): 35 -9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22451183

  2. Las mujeres con hepatitis B pueden amamantar a sus hijos. Al Día. Noticias de salud [Internet]. 2011 [citado 8 jul 2014]; mayo 12. Disponible en: http://boletinaldia.sld.cu/aldia/2011/05/12/las-mujeres-con-hepatitis-b-pueden-amamantar-a-sus-hijos/ VERSION ON-LINE: ISSN 1028-4818 Multimed. Revista Médica. Granma RPNS 12

  3. Ledinghen V.de, vergniol J, Barthe C, Foucher J, Chermak F, Le Bail B. Non-invasive tests forfibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther [Internet]. 2013 [citado 8 jul 2014]; 37(10):979-88. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Non-invasive+tests+forfibrosis+and+liver+stiffness+predict+5-year+survival+of+patients+chronically+infected+with+hepatitis+B+virus

  4. Bello Corredor M, Rodríguez Lay L. de los A, Gutiérrez Moreno A, Sariego Frómeta S, Montalvo Villalba MC, Sánchez Sol A. Detección de marcadores de hepatitis B y hepatitis C en pacientes VIH positivos, 2000-2004. Rev Cubana Med trop [Internet]. 2005 [citado 8 jul 2014]; 57(3): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602005000300009&lng=es&nrm=iso&tlng=es

  5. Hernández Ojeda OJ, Osorio Pagola MF, Martínez Martínez O, Monzón Vega D, Vega Galindo M. Evolución bioquímica y respuesta histológica de pacientes con hepatitis C bajo tratamiento antiviral. Medisur [Internet]. 2011 [citado 8 jul 2014]; 9(3): Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/1484/6654

  6. Méndez Chacón P, Vidalon A, Vildosola H. Factores de riesgo de Hepatitis C en hemodialisis y su impacto en la lista de espera para trasplante renal. Rev Gastroenterol Perú [Internet]. 2005 [citado 8 jul 2014]; 25(11): Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1022-51292005000100002&script=sci_arttext

  7. Ustáriz García C, Rodríguez Lay L. de los A, Delgado González G, Alfaro Amigó A, Gautier du Défaix Gómez H, Bencomo Hernández A et al . Frecuencia de hepatitis B y C en niños con hemopatías malignas. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2006 Ago [citado 08 Jul 2014] ; 22(2): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892006000200005&lng=es.

  8. Mulet Pérez A, Pullés Labadié M, Gámez Escalona M, Mulet Gámez A, Díaz Santos O, Infante Velázquez M. Hepatitis viral aguda C: tratamiento con altas VERSION ON-LINE: ISSN 1028-4818 Multimed. Revista Médica. Granma RPNS 13 dosis de Interferón alfa-2b humano recombinante (Heberon alfa R). Rev Cub Med Mil [Internet]. 2009 Mar [citado 08 jul 2014 ] ; 38(1): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572009000100012&lng=es.

  9. Barrios Camba J, Leyva de la Torre C, Chávez Moreno NJ, Cabrera Yero Y, Márquez Márquez DR. Infección por virus de la hepatitis b y c en pacientes de hemodiálisis. Rev Ciencias Médicas [Internet]. 2008 Dic [citado 2014 Jul 08]; 12(2): 48-60. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942008000200007&lng=es.

  10. Sánchez Rodríguez YA, Arús Soler E, Grá Oramas B, López Saura P, Nodarse Cuní H. Interferón alfa 2b recombinante más ribavirina en el tratamiento de la hepatitis crónica C. Rev cubana med [Internet]. 2010 Jun [citado 08 jul 2014 ] ; 49(2): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232010000200002&lng=es.

  11. Martínez Córdova Z, Peña Fresneda N. Prevalencia de anticuerpos anti-VHC y del antígeno de superficie de la hepatitis B en pacientes tratados con hemodiálisis. Rev cubana med [Internet]. 2008 Mar [citado 08 jul 2014] ; 47(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232008000100006&lng=es.




2020     |     www.medigraphic.com